Clinical trial

A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or…

NCT00377299 · University of Texas Southwestern Medical Center, Other · Completed

Key facts

NCT number NCT00377299
Title A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
Official title A Double-blind, Placebo-controlled Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
Lead sponsor University of Texas Southwestern Medical Center, Other
Collaborators Stanley Medical Research Institute
Status Completed
Study type Interventional
Conditions Amphetamine Abuse, Amphetamine Dependence, Bipolar Disorder, Major Depressive Disorder
Intervention type Drug
Interventions Citicoline, Placebo
Enrollment 60
Start date Oct 1, 2006
Primary completion May 1, 2009
Completion May 1, 2009
First posted Sep 18, 2006
Last update posted Aug 8, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies